norfloxacin and fosfomycin

norfloxacin has been researched along with fosfomycin in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	13 (30.23)	18.7374
1990's	16 (37.21)	18.2507
2000's	7 (16.28)	29.6817
2010's	7 (16.28)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P	1
Awuah, E; Barker, C; Brown, ED; Capretta, FA; Das, R; Gerritsma, DA; Lebert, J; Melacini, G; Pathania, R; Zlitni, S	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Campillo, NE; Guerra, A; Páez, JA	1
Blango, MG; Mulvey, MA	1
Allison, SE; Barker, CA; Brown, ED; Capretta, AA; Das, R; Melacini, G; Nguyen, ND; Zlitni, S	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fujita, Y; Isshiki, K; Kato, H; Katsu, T; Masuda, K; Miyagawa, A; Osawa, K; Yamamura, H	1
Cortés, R; Lou Arnal, S; Orozco, F; Pascual, T; Sunyer, L	1
de Jong, Z; Plante, P; Pontonnier, F	1
Barry, AL; Fuchs, PC	1
Battaglia, M; Di Lorenzo, V; Ditonno, P; Selvaggi, FP; Traficante, A	1
Ambrosi, G; Bucci, L; Ferraro, G; Palmieri, G; Palmieri, R	1
Reynaert, J; Van Eyck, D; Vandepitte, J	1
Boerema, JB; Willems, FT	1
Hayashi, I; Hirai, K; Irikura, T; Niwata, Y; Onuma, K; Suzue, S	1
Armynot du Chatelet, AM; Attisso, MA; Maillols, M; Simeon de Buochberg, M; Zuccarelli, M	1
Attisso, MA; Dusart, G; Maillols, H; Simeon de Buochberg, M; Zuccarelli, M	1
Fillastre, JP; Humbert, G; Lemeland, JF; Thauvin, C	1
Fontana, R; Meloni, GA; Rossi, L	1
Dubini, F; Riviera, L	2
Caillon, J; Dellamonica, P; Drugeon, HB	1
Dubini, F; Riviera, L; Visconti, A	1
Bebear, C; Lafferriere, C; Noury, P; Quentin, C; Saivin, S	1
Albini, E; Belluco, G; Marca, G	1
Bebear, C; Laurent, C; Noury, P; Quentin, C; Saivin, S	1
Borsotto, M; Carlone, NA; Cuffini, AM; Savoia, D	1
Chisaki, T; Hinotani, K; Miyazaki, K; Shimizu, T	1
Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y	1
Baquero, F; Cisterna, R; García-Rodríguez, JA; Gobernado, M; Liñares, F; Martín-Luengo, F; Piédrola, G; Trujillano Martín, I	1
Maruyama, S; Sakata, H	1
Uno, Y	1
Harada, H; Kita, E; Kurioka, T; Yunou, Y	1
Fujii, J; Taniguchi, H; Yoshida, S; Yoshimura, K	1
Koga, Y; Sawamura, S; Tanaka, K	1
Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K	1
Fukuyama, M; Furuhata, K; Hara, T; Oonaka, K; Sunakawa, K	1
Lobel, B	1
Tabata, M; Takata, T; Tsuruoka, T; Watabe, H	1
Ishitobi, J; Kamiya, A; Oie, S; Sawa, A; Tomita, M	1
Bertrand, X; Faller, JP; Hoen, B; Leroy, J; Sekri, D; Slekovec, C; Talon, D; Vernaz-Hegi, N	1

Reviews

2 review(s) available for norfloxacin and fosfomycin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories. International journal of antimicrobial agents, 2003, Volume: 22 Suppl 2 Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fosfomycin; Humans; Longitudinal Studies; Meta-Analysis as Topic; Nitrofurantoin; Norfloxacin; Treatment Outcome; Trimethoprim; Urinary Tract Infections	2003

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories.

International journal of antimicrobial agents, 2003, Volume: 22 Suppl 2

Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fosfomycin; Humans; Longitudinal Studies; Meta-Analysis as Topic; Nitrofurantoin; Norfloxacin; Treatment Outcome; Trimethoprim; Urinary Tract Infections

2003

Trials

6 trial(s) available for norfloxacin and fosfomycin

Article	Year
[Single oral dose of phosphomycin trometamol versus pipemidic acid and norfloxacin in treating uncomplicated low-level urinary tract infections]. Atencion primaria, 1992, Volume: 10, Issue:9 Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Female; Fosfomycin; Humans; Middle Aged; Norfloxacin; Pipemidic Acid; Prospective Studies; Single-Blind Method; Tromethamine; Urinary Tract Infections	1992
Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections. Urologia internationalis, 1991, Volume: 46, Issue:4 Topics: Drug Evaluation; Female; Fosfomycin; Humans; Norfloxacin; Urinary Tract Infections	1991
Fosfomycin trometamol (Monuril) versus norfloxacin in single dose for adult female uncomplicated UTIs. Multicenter randomized, double-blind study. Chemotherapy, 1990, Volume: 36 Suppl 1 Topics: Adolescent; Adult; Aged; Bacteriuria; Double-Blind Method; Drug Administration Schedule; Female; Fosfomycin; Humans; Middle Aged; Norfloxacin	1990
Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections of the elderly. Chemotherapy, 1990, Volume: 36 Suppl 1 Topics: Aged; Drug Administration Schedule; Female; Fosfomycin; Humans; Male; Norfloxacin; Remission Induction; Urinary Tract Infections	1990
Single dose fosfomycin trometamol versus multiple dose norfloxacin over three days for uncomplicated UTI in general practice. Infection, 1990, Volume: 18 Suppl 2 Topics: Adolescent; Adult; Aged; Cystitis; Drug Administration Schedule; Escherichia coli; Female; Fosfomycin; Humans; Middle Aged; Norfloxacin; Organization and Administration; Time Factors; Urinary Tract Infections	1990
Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice. Infection, 1990, Volume: 18 Suppl 2 Topics: Adolescent; Adult; Bacteriuria; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Escherichia coli; Female; Fosfomycin; Humans; Middle Aged; Norfloxacin; Pyuria; Remission Induction; Time Factors; Urinary Tract Infections	1990

Other Studies

35 other study(ies) available for norfloxacin and fosfomycin

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms. Journal of medicinal chemistry, 2007, Aug-23, Volume: 50, Issue:17 Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship	2007
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting. Nature chemical biology, 2009, Volume: 5, Issue:11 Topics: Anti-Bacterial Agents; Cell Division; Chromatography, Liquid; Cycloserine; Doxorubicin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Genes, Bacterial; Genome, Bacterial; Genomics; Lipoproteins; Mass Spectrometry; Molecular Chaperones; Periplasmic Binding Proteins; Pseudomonas aeruginosa; Sulfamethoxazole; Suppression, Genetic; Trimethoprim	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium	2010
Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA. Bioorganic & medicinal chemistry letters, 2013, Apr-15, Volume: 23, Issue:8 Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Proteins; Lipoproteins; Molecular Chaperones; Periplasmic Binding Proteins; Structure-Activity Relationship; Thiourea	2013
Gramicidin S-inspired antimicrobial cyclodextrin to disrupt gram-negative and gram-positive bacterial membranes. MedChemComm, 2019, Aug-01, Volume: 10, Issue:8 Topics:	2019
In vitro susceptibility testing procedures for fosfomycin tromethamine. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:6 Topics: Bacteria; Fosfomycin; Glucose-6-Phosphate; Glucosephosphates; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1991
[Combination effects of norfloxacin and fosfomycin against respiratory infections]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1987, Volume: 61, Issue:12 Topics: Adult; Aged; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Middle Aged; Norfloxacin; Respiratory Tract Infections	1987
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus]. Pathologie-biologie, 1988, Volume: 36, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Penicillin G; Vancomycin	1988
[Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis]. Pathologie-biologie, 1988, Volume: 36, Issue:5 Topics: Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Vancomycin	1988
Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:6 Topics: Animals; Anti-Infective Agents; Endocarditis, Bacterial; Fosfomycin; Male; Methicillin; Norfloxacin; Pefloxacin; Penicillin Resistance; Rats; Rats, Inbred Strains; Staphylococcal Infections	1988
In vitro testing of the antibacterial activity of fosfomycin trometamol against urinary pathogens. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:1 Topics: Bacteria; Drug Combinations; Drug Resistance, Microbial; Fosfomycin; Humans; Microbial Sensitivity Tests; Mutation; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Urine	1988
Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Bacteria; Cystitis; Drug Combinations; Fosfomycin; Humans; Male; Models, Biological; Norfloxacin; Pipemidic Acid; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urine	1988
Treatment of experimental cystitis in the rat with a single dose of fosfomycin trometamol. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:1 Topics: Administration, Oral; Animals; Bacterial Infections; Cystitis; Drug Combinations; Fosfomycin; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1988
[Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination]. Pathologie-biologie, 1987, Volume: 35, Issue:5 Topics: Anti-Bacterial Agents; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus aureus; Time Factors; Vancomycin	1987
[Experimental cystitis in the rat and the therapeutic effect of a single dose of fosfomycin trometamol]. Annali dell'Istituto superiore di sanita, 1987, Volume: 23, Issue:4 Topics: Animals; Cystitis; Drug Combinations; Drug Evaluation, Preclinical; Escherichia coli Infections; Fosfomycin; Klebsiella Infections; Norfloxacin; Pipemidic Acid; Proteus Infections; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1987
In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method. Drugs under experimental and clinical research, 1987, Volume: 13, Issue:4 Topics: Anti-Bacterial Agents; Drug Antagonism; Drug Interactions; Drug Synergism; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Thienamycins	1987
Influence of pH, inoculum and media on the in vitro bactericidal activity of fosfomycin trometamol, norfloxacin and cotrimoxazole. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:4 Topics: Culture Media; Drug Combinations; Escherichia coli; Fosfomycin; Hydrogen-Ion Concentration; In Vitro Techniques; Microbial Sensitivity Tests; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urine	1986
[In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)]. Pathologie-biologie, 1987, Volume: 35, Issue:2 Topics: Anti-Bacterial Agents; Drug Synergism; Fosfomycin; Humans; Imipenem; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus; Thienamycins	1987
Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents. European urology, 1987, Volume: 13 Suppl 1 Topics: Bacterial Adhesion; Drug Combinations; Escherichia coli; Fosfomycin; Hemagglutination; Humans; Microbial Sensitivity Tests; Norfloxacin; Proteus mirabilis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	1987
[Initial treatment at an outbreak of E. coli O-157:H7 infection: especially with respect to therapy in the emergency]. The Japanese journal of antibiotics, 1997, Volume: 50, Issue:10 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Child; Disease Outbreaks; Emergencies; Escherichia coli Infections; Escherichia coli O157; Female; Foodborne Diseases; Fosfomycin; Humans; Male; Norfloxacin	1997
[The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157]. The Japanese journal of antibiotics, 1997, Volume: 50, Issue:10 Topics: Aerobiosis; Ampicillin; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter jejuni; Cefaclor; Cephalosporins; Chloramphenicol; Drug Resistance, Microbial; Enteritis; Escherichia coli O157; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Penicillins; Salmonella; Tetracycline; Vibrio parahaemolyticus	1997
In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study. Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Excipients; Fosfomycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Norfloxacin; Spain; Tromethamine; Urinary Tract Infections	1997
[Result of antibiotic therapy for children with Escherichia coli O26:H11 infection]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1998, Volume: 72, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Disease Outbreaks; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Japan; Kanamycin; Norfloxacin; Retrospective Studies	1998
[Combination effect of fosfomycin otic solution and norfloxacin against chronic otitis media]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1999, Volume: 73, Issue:4 Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Disease; Drug Therapy, Combination; Fosfomycin; Humans; Norfloxacin; Otitis Media; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus	1999
Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:8 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Toxins; Brain Chemistry; Disease Models, Animal; Disease Progression; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Kanamycin; Mice; Mice, Inbred C57BL; Norfloxacin; Protein-Energy Malnutrition; Reference Values; Sensitivity and Specificity; Shiga Toxins; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	1999
Chemotherapy for enterohemorrhagic Escherichia coli O157:H infection in a mouse model. FEMS immunology and medical microbiology, 1999, Volume: 26, Issue:2 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Colony Count, Microbial; Drug Synergism; Enterotoxins; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Injections, Intraperitoneal; Kanamycin; Male; Mice; Mice, Inbred ICR; Minocycline; Mitomycin; Norfloxacin; Shiga Toxin 2	1999
[Therapeutic effects of antibiotics against enterohemorrhagic Escherichia coli (EHEC) O157:H7 (O157) infection: in vivo analysis using germfree mice]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1999, Volume: 73, Issue:10 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Disease Models, Animal; Escherichia coli Infections; Escherichia coli O157; Fosfomycin; Germ-Free Life; Male; Mice; Mice, Inbred BALB C; Norfloxacin; Shiga Toxin 1; Time Factors	1999
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]. The Japanese journal of antibiotics, 1999, Volume: 52, Issue:8 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1	1999
[Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis]. The Japanese journal of antibiotics, 2000, Volume: 53, Issue:7 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Blood; Campylobacter; Electrolytes; Enteritis; Escherichia coli; Escherichia coli O157; Fosfomycin; Humans; Hydrogen-Ion Concentration; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Salmonella; Shigella	2000
[Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins]. The Japanese journal of antibiotics, 2003, Volume: 56, Issue:6 Topics: Ampicillin; Anti-Bacterial Agents; Bacteriolysis; Cell Wall; Chloramphenicol; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Kanamycin; Norfloxacin; Shiga Toxins	2003
In vitro bactericidal activity of antimicrobial agents against enterohaemorrhagic Escherichia coli. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:5 Topics: Anti-Bacterial Agents; Cefoperazone; Electrophoresis, Gel, Pulsed-Field; Escherichia coli O157; Fosfomycin; Kanamycin; Microbial Sensitivity Tests; Norfloxacin	2004
Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns. International journal of clinical pharmacy, 2012, Volume: 34, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Attitude of Health Personnel; Drug Prescriptions; Drug Utilization; Education, Medical, Continuing; Female; Fosfomycin; France; General Practitioners; Guideline Adherence; Health Knowledge, Attitudes, Practice; Humans; Middle Aged; Nitrofurantoin; Norfloxacin; Practice Guidelines as Topic; Practice Patterns, Physicians'; Program Evaluation; Regression Analysis; Time Factors; Urinary Tract Infections; Young Adult	2012